These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 34792009)

  • 1. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
    Ma G; Yang L; Dong J; Zhang L
    Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
    Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
    Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma.
    Li A; Zhang K; Zhou J; Li M; Fan M; Gao H; Ma R; Gao L; Chen M
    Int J Biol Macromol; 2024 Jun; 272(Pt 2):132797. PubMed ID: 38848833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma.
    Zhang L; Wang S; Wang L
    BMC Cancer; 2024 Oct; 24(1):1235. PubMed ID: 39375639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGO2 as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma.
    Chen Y; Xiang T
    Front Biosci (Landmark Ed); 2024 Aug; 29(9):314. PubMed ID: 39344317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-coding RNA LINC00473 Promotes Breast Cancer Progression
    Zhang C; Yang T
    Protein Pept Lett; 2023; 30(1):72-84. PubMed ID: 36305147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major Facilitator Superfamily Domain Containing 12 Is Overexpressed in Lung Cancer and Exhibits an Oncogenic Role in Lung Adenocarcinoma Cells.
    Zhao W; Hu X; Chen Z; Li X
    DNA Cell Biol; 2024 Jul; 43(7):331-340. PubMed ID: 38687351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tRF-Val-CAC-010 in lung adenocarcinoma: implications for tumorigenesis and metastasis.
    Luo LL; Cao Y; Zhang JJ; Xie YX; Li L; Yang H; Long ZB; Wang L; Wang WP
    BMC Cancer; 2024 Aug; 24(1):1033. PubMed ID: 39169309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
    Zhang H; Cao Y; Tang J; Wang R
    Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression.
    He Y; Wang Y; Luo Z; Zhang X; Bai H; Wang J
    Cell Signal; 2024 Aug; 120():111216. PubMed ID: 38729325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of ERO1L attenuates tumor growth, migration and invasion in lung adenocarcinoma through Wnt/β‑catenin pathway.
    Zhang S; Zhang M; Ma W; Wang L; Yu B
    Biotechnol Genet Eng Rev; 2024 Nov; 40(3):1910-1923. PubMed ID: 37014092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway.
    Xu D; Wang Z; Li F
    Crit Rev Immunol; 2024; 44(6):49-61. PubMed ID: 38848293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
    Liu Z; Hu Z; Cai X; Liu S
    Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
    Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma.
    Tang S; Ni J; Chen B; Sun F; Huang J; Ni S; Tang Z
    BMC Cancer; 2022 May; 22(1):525. PubMed ID: 35534807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
    Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
    Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
    [No Abstract]   [Full Text] [Related]  

  • 20. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
    Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B
    Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.